Alexandra Balcom, Chief Financial Officer at Nuvalent, Inc. (NUVL), sold 11,430 shares at $94.87 ($1.1M) on 2026-06-01, disclosed to the SEC on 2026-06-03.
Scheduled sale ($1.1M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $94.87 | 960 | $91K | 8.1% |
| 2 | $95.99 | 2,170 | $208K | 18.5% |
| 3 | $97.68 | 900 | $88K | 7.8% |
| 4 | $98.57 | 1,200 | $118K | 10.5% |
| 5 | $99.86 | 3,133 | $313K | 27.7% |
| 6 | $100.65 | 2,588 |
| $260K |
| 23.1% |
| 7 | $101.79 | 279 | $28K | 2.5% |
| 8 | $103.84 | 200 | $21K | 1.8% |
| Total | $98.69 avg | 11,430 | $1.1M | 100% |
| Filing → |
| NUVL | SELL | 2026-04-03 | $1.2M | — | Filing → |
| NUVL | SELL | 2026-03-26 | $2.5M | — | Filing → |
| NUVL | SELL | 2026-01-07 | $721K | — | Filing → |